These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7551946)

  • 21. Postsurgical adjuvant therapy in stages I, II, and IIIA non-small cell lung cancer.
    Lad TE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1111-9. PubMed ID: 1962778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801).
    Kawaguchi K; Yokoi K; Niwa H; Ohde Y; Mori S; Okumura S; Shiono S; Ito H; Yano M; Shigemitsu K; Hiramatsu Y; Okami J; Saka H;
    Lung Cancer; 2017 Feb; 104():79-84. PubMed ID: 28213006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
    Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
    Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
    Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of localized non-small cell lung cancer (take home messages).
    Baumann M; Stamatis G; Thomas M
    Lung Cancer; 2001 Sep; 33 Suppl 1():S47-9. PubMed ID: 11576707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.
    Bonomi P; Gale M; Rowland K; Taylor SG; Purl S; Reddy S; Lee MS; Phillips A; Kittle CF; Warren W
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):247-52. PubMed ID: 1846847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group.
    Weiden PL; Piantadosi S
    J Natl Cancer Inst; 1991 Feb; 83(4):266-73. PubMed ID: 1847220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
    Wolf M
    Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
    Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Postoperative adjuvant therapy in combined lung cancer treatment].
    Cicenas S; Piscikas DA; Jakubauskiene R
    Medicina (Kaunas); 2004; 40 Suppl 1():156-60. PubMed ID: 15079128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemotherapy for stage IIIa non-small cell lung cancer.
    Fossella FV; Rivera E; Roth JA
    Curr Opin Oncol; 1996 Mar; 8(2):106-11. PubMed ID: 8727302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
    Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis.
    Suzuki M; Kimura H; Iwai N; Fujisawa T
    Oncol Rep; 2000; 7(3):545-9. PubMed ID: 10767366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current state of the art in treating stage IIIA (N2) lung cancer.
    Martini N
    Ann Oncol; 1998 Mar; 9(3):243-5. PubMed ID: 9602255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.